STOCK TITAN
  1. Home
  2. Sec-filings
  3. hcwc
  4. [Form 4] HEALTHY CHOICE WELLNESS CORP. Insider Trading Activity

HCWC (HCWC) CFO Ollet John gains 73,640 vested restricted shares in Form 4

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

HEALTHY CHOICE WELLNESS CORP. director and CFO Ollet John acquired 73,640 shares of Class A common stock through a restricted stock award that vested on May 25, 2026 at no cost. Following this vesting, he holds 551,817 shares directly, plus substantial additional unvested restricted stock subject to multi‑year quarterly vesting schedules.

Positive

  • None.

Negative

  • None.
Insider Ollet John
Role Chief Financial Officer
Type Security Shares Price Value
Grant/Award Class A Common Stock 73,640 $0.00 --
Holdings After Transaction: Class A Common Stock — 551,817 shares (Direct, null)
Footnotes (1)
  1. Restricted stock award of 73,640 shares vested on May 25, 2026 Registrant's holdings include (a) 551,817 shares of common stock held directly, (b) 300,000 unvested shares of restricted common stock granted on November 12, 2025, which is a time-based restricted stock award that vests in six quarterly installments of 50,000 shares with next vesting on August 12, 2026, and (c) 515,476 unvested shares of restricted common stock granted on February 25, 2026, which is a time-based restricted stock award that vests in eight equal quarterly installments of 73,640 shares with next vesting on August 25, 2026.. The Restricted Stock will immediately vest upon the occurrence of certain change of control events set forth in the Reporting Person's Restricted Stock Award Agreements.
Restricted shares vested 73,640 shares Restricted stock award vested on May 25, 2026
Shares after transaction 551,817 shares Direct common stock holdings following vesting
Unvested restricted stock (Nov 2025 grant) 300,000 shares Granted November 12, 2025; time-based vesting
Unvested restricted stock (Feb 2026 grant) 515,476 shares Granted February 25, 2026; time-based vesting
Quarterly vesting tranche size (Feb 2026 grant) 73,640 shares Eight equal quarterly installments; next vesting August 25, 2026
Quarterly vesting tranche size (Nov 2025 grant) 50,000 shares Six quarterly installments; next vesting August 12, 2026
Per-share transaction price $0.0000 per share Reported for the 73,640-share restricted stock vesting
restricted stock award financial
"Restricted stock award of 73,640 shares vested on May 25, 2026"
A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.
time-based restricted stock award financial
"which is a time-based restricted stock award that vests in six quarterly installments"
quarterly installments financial
"vests in six quarterly installments of 50,000 shares with next vesting on August 12, 2026"
change of control events financial
"The Restricted Stock will immediately vest upon the occurrence of certain change of control events"
Restricted Stock Award Agreements financial
"set forth in the Reporting Person's Restricted Stock Award Agreements"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ollet John
(Last)(First)(Middle)
3800 NORTH 28TH WAY, UNIT 1
(Street)
HOLLYWOOD FLORIDA 33020
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
HEALTHY CHOICE WELLNESS CORP. [ HCWC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/25/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock05/25/2026A73,640(1)A$0551,817(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted stock award of 73,640 shares vested on May 25, 2026
2. Registrant's holdings include (a) 551,817 shares of common stock held directly, (b) 300,000 unvested shares of restricted common stock granted on November 12, 2025, which is a time-based restricted stock award that vests in six quarterly installments of 50,000 shares with next vesting on August 12, 2026, and (c) 515,476 unvested shares of restricted common stock granted on February 25, 2026, which is a time-based restricted stock award that vests in eight equal quarterly installments of 73,640 shares with next vesting on August 25, 2026.. The Restricted Stock will immediately vest upon the occurrence of certain change of control events set forth in the Reporting Person's Restricted Stock Award Agreements.
/s/ Martin Schrier, as Attorney-in-Fact for John Ollet05/25/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did HCWC CFO Ollet John report on this Form 4?

HCWC CFO and director Ollet John reported acquiring 73,640 shares of Class A common stock. The shares came from a restricted stock award that vested on May 25, 2026, rather than from any open-market purchase, reflecting compensation-related equity vesting.

How many HCWC shares did Ollet John receive in this restricted stock vesting?

Ollet John received 73,640 shares of Class A common stock. A footnote explains this was a restricted stock award that vested on May 25, 2026, with a reported transaction price per share of $0.0000, indicating no cash outlay by the insider.

What are Ollet John’s HCWC shareholdings after the reported transaction?

After the vesting, Ollet John holds 551,817 shares of common stock directly. A footnote adds that his overall equity position also includes significant unvested restricted stock awards that will vest in scheduled quarterly installments over time, subject to continued service and award terms.

What additional unvested HCWC restricted stock does Ollet John hold?

Footnotes state he holds 300,000 unvested restricted shares from a November 12, 2025 grant and 515,476 unvested restricted shares from a February 25, 2026 grant. These time-based awards vest in specified quarterly installments under their respective schedules.

How do the HCWC restricted stock awards for Ollet John vest over time?

The 300,000-share grant vests in six quarterly installments of 50,000 shares, with the next vesting on August 12, 2026. The 515,476-share grant vests in eight equal quarterly installments of 73,640 shares, with the next vesting on August 25, 2026, per the footnotes.

What happens to Ollet John’s HCWC restricted stock on a change of control event?

Footnotes explain that the restricted stock will immediately vest upon certain change of control events described in his Restricted Stock Award Agreements. This means specified corporate transactions could accelerate vesting, removing the remaining time-based vesting schedule conditions.

Was the HCWC Form 4 transaction an open-market purchase by Ollet John?

No, the Form 4 reflects a grant or award acquisition, not an open-market purchase. The 73,640 shares came from a restricted stock award vesting at a reported price of $0.0000 per share, consistent with compensation rather than a cash-funded market transaction.